ESCMID Global 2024
Cefiderocol May Be Game Changer for Acinetobacter
Cefiderocol may be a game changer for treating resistant Acinetobacter in patients with limited or no alternative ...
FEBRUARY 21, 2025

Asymptomatic Mpox Points to Need for Increased Testing and Vaccination
Healthcare providers should consider early testing of the sexual contacts of people with mpox, regardless of ...
MAY 10, 2024

You Are Never Too Old for an STI
Infectious disease expert addresses how to manage the rise in sexually transmitted infections in older adults.
MAY 1, 2024

Measles Cases Worldwide Almost Doubled in 2023
The number of measles cases throughout the world almost doubled in 2023, and this unfortunate trend seems to be ...
MAY 1, 2024

Are Dogs and Cats Passing Superbugs to Owners?
The study found evidence of MDR bacteria being passed between sick cats and dogs and their healthy owners, raising ...
MAY 1, 2024

Previous Smallpox Vaccination Boosts Immunogenicity of Mpox Vaccine
Immunogenicity after mpox vaccination lasted longer among people who had received a smallpox vaccination as a child ...
MAY 1, 2024

U.S. Black Women Hospitalized With Resistant Bacteremia at Higher Risk for Death
Black women hospitalized with a resistant bacteremia were twice as likely to die as Black men or white women, even ...
APRIL 29, 2024

Long COVID No Different From Other Post-Viral Syndromes 1 Year After Infection
Long COVID appears to manifest as a post-viral syndrome indistinguishable from other respiratory illnesses, ...
APRIL 29, 2024

People With MS Disproportionately at Risk for Hospitalization and Death From COVID-19
Even after receiving at least three COVID-19 vaccinations, people with MS had an almost six times greater risk for ...
APRIL 29, 2024

CRISPR-Cas Gene Editing ‘Completely’ Eliminated HIV in Cell Culture
A team of researchers in the Netherlands said the latest CRISPR-Cas gene editing technology can be used to ...
APRIL 24, 2024
